The role of the CCR4-NOT complex and mRNA regulatory elements in determining protein synthesis, destination and complex formation.
Lead Research Organisation:
University of Glasgow
Department Name: College of Medical, Veterinary, Life Sci
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Recent evidence indicates that CCR4-NOT is of central importance in regulation of the spatial proteome, but the underlying mechanisms by which it responds to information within mRNA sequence to regulate protein expression and location are poorly understood. This proposal will address these questions by combining global interrogation of the regulation of the subcellular RNAome and proteome by CCR4-NOT with detailed mechanistic analysis of its regulation of cellular and viral mRNA targets at the ER, and how this relates to miRNA function and detection of ribosome pausing.
Using Huh7 liver cells as a model for ER-associated translation, high expression of miR-122, and HCV replication, we will couple rapid CNOT1 depletion by the auxin-inducible degron system with the LOPIT and LoRNA methods that were recently developed in the Lilley lab. These methods will give an unprecedented overview of the subcellular distribution of proteins and RNAs, respectively, and how they are regulated by CCR4-NOT. We will also apply the LoRNA method to obtain the first global characterisation of miRNA localisation across the cell. Immunofluorescence and in situ hybridisation will be used to confirm important results.
In parallel, we will directly investigate how CCR4-NOT functions at the ER, using membrane-cytoplasmic fractionation and ribosome profiling to characterise how CNOT1 depletion regulates ribosome pausing and ER targeting. Detailed mechanistic analysis of the effects of CCR4-NOT and miRNAs on translation and stability of cellular targets and HCV RNA will use approaches including siRNA-mediated knockdown, 4-thio-uridine labelling of nascent RNA and poly(A) tail analysis in membrane-cytoplasmic fractions. Reporter assays will determine the role of ribosome pause sites and UTR elements in dictating miRNA and CCR4-NOT function at the ER, and in mRNA and miRNA subcellular localisation.
Using Huh7 liver cells as a model for ER-associated translation, high expression of miR-122, and HCV replication, we will couple rapid CNOT1 depletion by the auxin-inducible degron system with the LOPIT and LoRNA methods that were recently developed in the Lilley lab. These methods will give an unprecedented overview of the subcellular distribution of proteins and RNAs, respectively, and how they are regulated by CCR4-NOT. We will also apply the LoRNA method to obtain the first global characterisation of miRNA localisation across the cell. Immunofluorescence and in situ hybridisation will be used to confirm important results.
In parallel, we will directly investigate how CCR4-NOT functions at the ER, using membrane-cytoplasmic fractionation and ribosome profiling to characterise how CNOT1 depletion regulates ribosome pausing and ER targeting. Detailed mechanistic analysis of the effects of CCR4-NOT and miRNAs on translation and stability of cellular targets and HCV RNA will use approaches including siRNA-mediated knockdown, 4-thio-uridine labelling of nascent RNA and poly(A) tail analysis in membrane-cytoplasmic fractions. Reporter assays will determine the role of ribosome pause sites and UTR elements in dictating miRNA and CCR4-NOT function at the ER, and in mRNA and miRNA subcellular localisation.
Organisations
People |
ORCID iD |
| Martin Bushell (Principal Investigator) |
Publications
Collart MA
(2023)
Roles of the CCR4-Not complex in translation and dynamics of co-translation events.
in Wiley interdisciplinary reviews. RNA
| Description | Bart's RNA and cancer meeting June 2023 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited speaker. I give a talk about our research and people were very positive and said it had changed the way they were thinking about translational control |
| Year(s) Of Engagement Activity | 2023 |
| Description | Belfast talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | I give a talk about our research and people were very positive and said it had changed the way they were thinking about translational control |
| Year(s) Of Engagement Activity | 2023 |
| Description | Feb congress Tours France |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | I give a talk about our research and people were very positive and said it had changed the way they were thinking about translational control |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://2023.febscongress.org/program |
| Description | Translation UK Keynote address Cambridge July 2023 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | I was asked to give the keynote address at the translation UK. I give a talk about our research and people were very positive and said it had changed the way they were thinking about translational control |
| Year(s) Of Engagement Activity | 2023 |